Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its corona vaccine Kumar Jeetendra | December 7, 2020 China’s Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its coronavirus vaccine, the companies said on Monday, as it anticipates efficacy data of its experimental shot this month. The investment deal also comes as Sinovac expands provide deals and trials of its experimental COVID-19 vaccine CoronaVac …
Coronavirus antibody: AstraZeneca applies for full regulatory endorsement in Brazil Kumar Jeetendra | January 30, 2021 Brazilian health regulator Anvisa said on January 29 that a COVID-19 vaccine developed by Oxford University and AstraZeneca had applied for full regulatory approval, in a positive development for the nation’s beleaguered vaccine rollout. The entry, the first of its kind in Brazil, was made by the federally funded Fiocruz Institute, which will manufacture the …
Sri Lanka endorses Pfizer COVID-19 vaccine for emergency use Kumar Jeetendra | May 8, 2021 Sri Lanka on Saturday approved Pfizer’s COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India. Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 …
Which COVID vaccine is ideal? Here’s the reason that is truly difficult to reply Kumar Jeetendra | June 17, 2021 With the rollout of COVID-19 vaccines accelerating, people are increasingly asking which vaccine is best? Even if we tried to answer this question, defining which vaccine is “best” is not simple. Does that mean the vaccine better at protecting you from serious disease? The one that protects you from whichever variant is circulating near you? …
